PUSH hat dies direkt geteilt
When we founded Aitiologic, we set out to answer a question: How much more could a blood sample tell us if we could better interpret the DNA it contains? Today, we’re announcing an oversubscribed €6.4 million seed round to advance that ambition, co-led by Heal Capital and Ananda Impact Ventures. Our Aitios® platform combines molecular signals from individual cell-free DNA molecules with AI to infer their tissue of origin and reveal tissue-specific biological changes. We’re starting with preeclampsia: identifying risk in the first trimester, using the same blood sample routinely collected for non-invasive prenatal testing. Earlier insight into maternal and placental health, without an additional blood draw – with the goal of guiding prevention and closer monitoring. What makes this milestone meaningful to me is the progress behind it. What began as a technology concept during my time at Siemens Healthineers has progressed to published clinical feasibility data, with large-scale validation now underway with The Fetal Medicine Foundation. I’m particularly pleased to welcome Gordon Sanghera, co-founder and former CEO of Oxford Nanopore Technologies, as an investor and advisory board member, and Rebecca Ertl as our Chief Medical Officer. Their experience will be invaluable as we advance toward clinical translation. Thank you to our co-leads, our early backers PUSH and LANA Ventures, and all our investors for their trust. To our clinical collaborators, including Professor Kypros Nicolaides and the Fetal Medicine Foundation, for helping us build the evidence. To FFG Österreichische Forschungsförderungsgesellschaft mbH, Austria Wirtschaftsservice (aws) and Wirtschaftsagentur Wien for supporting our development along the way. And above all, to my co-founders and the aitiologic team for the work that makes this possible. Preeclampsia is our first application. Our ambition is to make tissue-resolved biology accessible from a routine blood draw – and translate that insight into earlier detection and better-informed care. https://lnkd.in/d24rga2p #LiquidBiopsy #Preeclampsia #WomensHealth #PrecisionMedicine